About: Carboplatin-Taxol-Bevacizumab Regimen     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : owl:Class, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:label
  • Carboplatin-Taxol-Bevacizumab Regimen
rdfs:subClassOf
Semantic_Type
  • Therapeutic or Preventive Procedure
Preferred_Name
  • Carboplatin-Taxol-Bevacizumab Regimen
UMLS_CUI
  • C1880001
ALT_DEFINITION
  • A chemotherapy combination used to treat advanced, nonsquamous non-small cell lung cancer. It includes the drugs carboplatin, paclitaxel (Taxol), and bevacizumab.NCI-GLOSS
PDQ_Open_Trial_Search_ID
  • 657275
PDQ_Closed_Trial_Search_ID
  • 657275
Legacy_Concept_Name
  • Carboplatin-Taxol-Bevacizumab_Regimen
FULL_SYN
  • carboplatin-Taxol-bevacizumab regimenPTNCI-GLOSSCDR0000663014
  • Carboplatin-Taxol-Bevacizumab RegimenPTNCI
  • Carbo-Taxol-Avastin RegimenSYNCI
  • carboplatin-paclitaxel-bevacizumab regimenPTNCI-GLOSSCDR0000663013
DEFINITION
  • A chemoimmunotherapy regimen consisting of carboplatin, paclitaxel and bevacizumab used to treat advanced stage, non-small cell lung cancer which is not of the squamous cell histology.NCI
DesignNote
  • Source: NCCN Guidelines 2007
code
  • C63413
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 48 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software